NCT04286386View on ClinicalTrials.gov

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

Active, not recruitingOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Prostate Adenocarcinoma
Interventions
OTHER

Hyperpolarized Carbon C 13 Pyruvate

Given IV

PROCEDURE

Magnetic Resonance Spectroscopic Imaging

Undergo MRSI

PROCEDURE

Surgical Procedure

Undergo standard of care surgery

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04286386 - Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam | Biotech Hunter | Biotech Hunter